Effect of pharmacologic treatments on the sleep of depressed patients
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 37 (2) , 85-98
- https://doi.org/10.1016/0006-3223(94)00135-p
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the ratNeuropharmacology, 1992
- Sleep and 5-HT2 receptor sensitivity in recovered depressed patientsJournal of Affective Disorders, 1992
- Effects of repeated ritanserin on middle-aged poor sleepersPsychopharmacology, 1989
- The Cholinergic Rapid Eye Movement Sleep Induction Test With RS-86Archives of General Psychiatry, 1989
- Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonismLife Sciences, 1989
- Rapid Eye Movement Sleep Characteristics During and After Mood-Disturbing EventsArchives of General Psychiatry, 1983
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981
- TrazodoneDrugs, 1981
- EEG sleep in primary depressionJournal of Affective Disorders, 1979
- Mono-amine oxidase inhibitors, sleep and moodElectroencephalography and Clinical Neurophysiology, 1970